Nateglinide
Product Images NDC 75834-205

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nateglinide (NDC 75834-205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nateglinide 01)

Chemical structure of nateglinide, showing its molecular framework with labeled chemical groups and molecular formula C14H27O3 indicated on the diagram.*

FDA Label Image

Principal Display Panel (60 mg Tablet Bottle Label)

NATEGLINIDE tablets, USP 60 mg, in a package label showing 100 tablets. The label includes storage instructions, manufacturer details (Cadila Pharmaceuticals Ltd., India), and labeler information (Nivagen Pharmaceuticals, Inc., Sacramento, CA). The label states it is Rx only and displays the NDC 75834-205-01.*

FDA Label Image

Principal Display Panel (120 mg Tablet Bottle Label)

NATEGLINIDE TABLETS, USP 120 mg label with count of 100 tablets. Manufactured by Cadila Pharmaceuticals Ltd., labeled for Nivagen Pharmaceuticals, Inc., Sacramento, CA. Includes dosage information, storage instructions, barcode, and toll-free contact number. The label is primarily white with green and blue graphics.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.